While Pharma is still waiting on DDMAC to release guidelines on what should and shouldn't be done in social media marketing, the FDA has released guidance on medical mobile apps. It primarily focuses on augmented regulated medical devices and turning mobile devices into medical devices. The goal of the guidance is to protect patient information and addresses the functionality of the devices. According to MM&M, guidance is missing on medical books turned into digital formats.
"The use of mobile medical apps on smart phones and tablets is revolutionizing healthcare delivery," said Jeffrey Shuren, M.D., J.D., director of the FDA's Center for Devices and Radiological Health, in a statement. "Our draft approach calls for oversight of only those mobile medical apps that present the greatest risk to patients when they don't work as intended."
ePharma West will help you sift through the guidance and prepare you for new regulation for social media. There are only 5 days left to register. Visit the ePharma West Webpage to download the brochure and register. And be sure to mention XP1656BLOG to save an additional 10%.
Do you think this release means we will see social media guidance shortly?